HealthCor Management
HealthCor Management L.P. is an employee-owned hedge fund sponsor based in New York City, with additional offices in London and Norwalk. Founded in 2005, the firm specializes in managing investments in the global healthcare, life sciences, and consumer sectors. It serves a diverse clientele, including investment companies, pension plans, sovereign wealth funds, and foreign official institutions. HealthCor employs a combination of bottom-up fundamental analysis and top-down assessments to guide its investment strategies, leveraging both in-house and external research to enhance decision-making. Its focus on the healthcare industry aims to deliver quality returns for its clients.
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.